Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its ...

Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, an investigational, once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated ...

Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...

Sagimet Biosciences (SGMT) announced that three poster presentations featuring additional analyses from the Phase 2b FASCINATE-2 study of ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...

MetaVia Inc. ( Nasdaq: MTVA) announced that a late-breaking abstract highlighting Phase 2a data from its DA-1241 program in presumed metabolic dysfunction-associated steatohepatitis (MASH) has been ...

On the eve of his New York retrial, the fallen mogul spends 23 hours a day alone in his cell, reading biographies and ...

Widow says President Museveni picked Maj John Kazoora’s medical bills even when they had fallen out politically ...

A hidden jury clue suggests that disgraced Hollywood film producer Harvey Weinstein's retrial may backfire spectacularly.

Poilievre promises costed party platform on Tuesday, Carney pledges $4 billion to provinces to build more hospitals and ...